The extrahepatopancreatic ducts as a novel source of hepatic progenitors

Information

  • Research Project
  • 10242937
  • ApplicationId
    10242937
  • Core Project Number
    R01DK124583
  • Full Project Number
    5R01DK124583-02
  • Serial Number
    124583
  • FOA Number
    PA-19-056
  • Sub Project Id
  • Project Start Date
    9/1/2020 - 4 years ago
  • Project End Date
    8/31/2023 - a year ago
  • Program Officer Name
    BURGESS-BEUSSE, BONNIE L
  • Budget Start Date
    9/1/2021 - 3 years ago
  • Budget End Date
    8/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    8/10/2021 - 3 years ago

The extrahepatopancreatic ducts as a novel source of hepatic progenitors

Project Summary While foregut endoderm research has primarily focused on the development and regeneration of the liver, pancreas, and intestine, relatively little attention have been placed on the nexus by which these organs are connected. The mammals and zebrafish the extrahepatopancreatic duct (EHPD) system functions as a tubular network joining the liver, pancreas, and gall bladder together with the duodenum. Extensive genetic and morphogenetic conservation between human and zebrafish EHPDs not only qualifies the zebrafish as a practical genetic model for this tissue, but also suggests more critical roles for the EHPDs beyond simply transporting hepatic bile and pancreatic enzymes. We propose here to leverage the zebrafish vertebrate model to rigorously explore the function of EHPD cells as a novel and significant source of progenitors for liver development, homeostasis, and regeneration. Using a zebrafish model that phenocopies hepatic biliary cell loss in Alagille Syndrome (ALGS), we found that agenesis of intrahepatic duct (IHD) cells, due to transient loss of the Notch ligand Jagged, can lead to a robust cellular response outside the liver, within the EHPD. Specifically, the EHPD cells react to the liver duct cell loss by proliferating excessively and contributing primarily to the regenerated IHD cells and hepatocytes also. These unexpected findings suggest that the EHPD system harbors multipotent progenitors that can contribute to the liver. Our discovery of multipotent progenitors residing in the EHPD leads to fundamental new questions: To what extent and by what mechanisms do the EHPD cells contribute to the liver during development, homeostasis, and regeneration? And how are these progenitors formed and maintained? We hypothesize that the EHPDs act as the initial source of nearly all progenitors for the liver. We posit that EHDP progenitors have high proliferative capacity and are maintained in an undifferentiated, quiescent state by FGF signaling. Further, we hypothesize that these EHPD cells are poised for expansion and migration to become distributed throughout the liver, ultimately adopting cholangiocyte or hepatocyte identity during development and homeostasis, and to a greater degree, in response to specific types of liver damage. Insufficient EHPD progenitors may lead to alternative mechanisms of regeneration such as transdifferentiation. Testing these hypotheses may lead to a unifying, dynamic liver regeneration model, whereby the availability of EHPDs progenitors is a significant determinant of which regenerative mechanism predominates. Uncovering a more fundamental role for the EHPD cells in liver regenerative biology will advance our understanding and treatment of liver diseases including ALGS and other cholangiopathies, as well as hepatocyte disorders. A central role for the EHPD in liver regeneration would also implicate it as a novel target tissue for liver therapies. We propose to investigate the lineage contribution of EHPD cells during liver development, homeostasis, and regeneration, and the genetic and cellular mechanisms driving this complex process.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R01
  • Administering IC
    DK
  • Application Type
    5
  • Direct Cost Amount
    220000
  • Indirect Cost Amount
    209000
  • Total Cost
    429000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
    NIDDK:429000\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    HBPP
  • Study Section Name
    Hepatobiliary Pathophysiology Study Section
  • Organization Name
    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
  • Organization Department
  • Organization DUNS
    020520466
  • Organization City
    LA JOLLA
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    920371005
  • Organization District
    UNITED STATES